EUVIMEDEUVIMED entdecken
Crossref

Targeted Hybrid Theranostic Nanocarriers Enhance Thrombolytic Therapy via the Integration of Chemical and Physical Action

Min Gao, Jinjin Lu, Jing Liang, Shuai Gao, Bowen Xiao, Tingting Liu, Xinyuan Zhang, Zhongtao Wen, Jinghua Chen iD, Yu Jiang, Yanjun Zhao iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c16918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Min Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carbohyrate Chemistry and Biotechnology (Jiangnan University), Ministry of Education, School of Life Sciences and Health Engineerin…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Thrombolytic Therapy, Theranostic Nanomedicine, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Key Laboratory of Carbohyrate Chemistry and Biotechnology, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesThrombolytic TherapyTheranostic NanomedicineThrombosisDrug CarriersUrokinase-Type Plasminogen ActivatorFibrinolytic AgentsGoldAnimalsMiceHumansPeptides

Stichwörter der Autor:innen

Active targetingAlbuminNanomedicinePhotothermal therapyThrombosis

Substanzen

GoldDrug CarriersUrokinase-Type Plasminogen ActivatorFibrinolytic AgentsPeptides

Autor:innen und Institutionen

  • Key Laboratory of Carbohyrate Chemistry and Biotechnology (Jiangnan University), Ministry of Education, School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
  • Department of General Practice, Jiangnan University Medical Center, Wuxi 214002, China.
  • Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, School of Pharmaceutical Science & Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China.

ORCID-Profile: Jinghua Chen, Yanjun Zhao

Förderung

  • Fundamental Research Funds for the Central Universities
  • Key Laboratory of Carbohyrate Chemistry and Biotechnology, Ministry of Education

Zitieren

APA

Gao, M., Lu, J., Liang, J., Gao, S., Xiao, B., Liu, T., Zhang, X., Wen, Z., Chen, J., Jiang, Y., & Zhao, Y. (2025). Targeted Hybrid Theranostic Nanocarriers Enhance Thrombolytic Therapy via the Integration of Chemical and Physical Action. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c16918

Vancouver

Gao M, Lu J, Liang J, Gao S, Xiao B, Liu T, et al. Targeted Hybrid Theranostic Nanocarriers Enhance Thrombolytic Therapy via the Integration of Chemical and Physical Action. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c16918

BibTeX
@article{Gao2025,
  author = {Gao, Min and Lu, Jinjin and Liang, Jing and Gao, Shuai and Xiao, Bowen and Liu, Tingting and Zhang, Xinyuan and Wen, Zhongtao and Chen, Jinghua and Jiang, Yu and Zhao, Yanjun},
  title = {Targeted Hybrid Theranostic Nanocarriers Enhance Thrombolytic Therapy via the Integration of Chemical and Physical Action},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c16918}
}
Kostenlos starten →